Legence stock
LGNNASDAQLegence Corp., IndustrialsISIN US52476L1098
43Score 43 out of 100, Weak
Price and trend
41 / 100
Price history
+2.3% in one yearThe chart shows daily closes over 1 year, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 41% below it.
Since September 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 50).
The price is 64% below its 52-week high. Largest decline in 1 year: 75% (May 2026 to November 2026).
Chart figures for advanced users
- SMA 50$46.76
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$62.77
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)50
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$25.41
- The lowest closing price of the last twelve months.
- Resistance$102.27
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Legence Corp. belongs to the Engineering & Construction industry (United States) and, with a market value of $5.13B, is number 52 of 110 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $2.55B (up 21.5% year on year) and a loss of $59.78M.
- For fiscal 2026, analysts expect on average revenue of $4.79B (up 87.7%) and adjusted earnings per share of $1.33.
Show more
- MEQIRI Score 43 out of 100 (Weak): rank 889 of 1023 in Industrials, median 61.
- Our model puts fair value at $53.16, with the price 30% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Growing faster than its industryRevenue up 27% a year since 2022, Engineering & Construction median 10.8%.Growth 83
Weaknesses
- Interest barely coveredOperating profit covers interest only 0.5 times.Stability 34
- Loss-makingLoss of $45.04M over the last 12 months.Fundamentals 46
- Volatile share priceVolatility 81% a year over the last 12 months.Stability 34
Its standout strengths are growth and valuation, while profitability and capital allocation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 42 to 43.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
Modestly undervaluedIn our model the price counts as cheap below $35.44 and expensive above $106.32 (uncertainty very high, based on the price swings of the past year).
Calculated with a cost of equity of 9.6%. At 10.6% the fair value would be $45.83, at 8.6% it would be $63.53.
Valuation metrics
From the cash-flow model alone; without earnings there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the quarter to 30 Jun 2026, revenue rose 111% on the same quarter a year earlier. Revenue has grown strongly since 2022, at around 27% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 21%, operating 4%, net −2%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 26 Mar 2027in 134 days
- Last reported
- 12 Nov 2026EPS reported $1.15 (expected $0.57)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $1.33+1.5%
- Revenue
- $4.79B+0.1%
- Earnings per share
- $2.65−1.0%
- Revenue
- $5.46B+0.2%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −3.3%2026 guidance raised sharply: revenue of $4.7 billion to $4.8 billion (previously $4.1 billion to $4.3 billion) and EBITDA of $565 million to $585 million (previously $470 million to $490 million).
“We're also raising our full year 2026 EBITDA guidance range by about 20% from prior guidance to $565 million to $585 million, up from $470 million to $490 million, again, just 3 months ago.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 13 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. One insider sold, $285,036 in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Legence
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
1023 rated companies in Industrials
- This company
- 43
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Engineering & Construction
The next larger and next smaller companies by market value
- Kandenko1942.T $5.65B68
- Granite ConstructionGVA $5.58B54
- Tutor PeriniTPC $5.33B63
- SwecoSWEC-B.ST $5.15B68
- CTF Services0659.HK $5.11B57
- BudimexBDX.WA $4.95B71
- Maire TecnimontMAIRE.MI $4.9B69
- Construction PartnersROAD $4.7B54
ETFs that hold Legence
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.06% | 0.30% | €4.22B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.06% | 0.30% | €2.17B |
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.06% | 0.30% | €185.82M |
Show 5 more
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.02% | 0.45% | €1.53B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.01% | 0.43% | €2.48B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.35% | €434.1M |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.01% | 0.30% | €944.34M |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.01% | 0.25% | €175.89M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 11 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.